Showing results (71-80 of 93) with videos related to
Sort By:
Pageof 10
Journal of Hepatology|October 27, 2010
Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patientsMarie-Louise C Vachon, Stephanie H Factor, Andrea D Branch, et al.Hepatology (Baltimore, Md.)|August 1, 2021
A Digital Case-Finding Algorithm for Diagnosed but Untreated Hepatitis C: A Tool for Increasing Linkage to Treatment and CureBrooke Wyatt, Ponni V Perumalswami, Anna Mageras, et al.Journal of Virological Methods|November 2, 2010
Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluidJulio A Gutierrez, Arielle L Klepper, John Garber, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapyJames F Crismale, Valérie Martel-Laferrière, Kian Bichoupan, et al.Plos One|October 9, 2014
Effect of cholecalciferol supplementation on inflammation and cellular alloimmunity in hemodialysis patients: data from a randomized controlled pilot trialLily Li, Marvin Lin, Maria Krassilnikova, et al.Hepatology (Baltimore, Md.)|September 20, 2016
Hepatitis C virus double-stranded RNA is the predominant form in human liver and in interferon-treated cellsArielle Klepper, Francis J Eng, Erin H Doyle, et al.Open Forum Infectious Diseases|October 30, 2019
Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative AdultsThomas L Nickolas, Michael T Yin, Ting Hong, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2016
Real-World Sustained Virologic Response Rates of Sofosbuvir-Containing Regimens in Patients Coinfected With Hepatitis C and HIVDavid Del Bello, Agnes Cha, Maria Sorbera, et al.Journal of Hepatology|September 1, 2022
IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver diseaseJiwoon Park, Yuanyuan Zhao, Fan Zhang, et al.Cancer Medicine|April 20, 2023
Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosisChiara Rocha, Erin H Doyle, Chip A Bowman, et al.Pageof 10